LabCorp secures new credit citing acquisitions as a motivation

Related tags Credit

Contract testing services supplier LabCorp has secured a credit facility with the Bank of America, citing capital expenditures and acquisitions among the potential uses of the funds.

News of the new agreement – which is worth a total $1bn (EUR765m) – follows just days after LabCorp completed its long sought acquisition of UK DNA testing services group Orchid Cellmark​.

LabCorp said: “The new facility will be used for general corporate purposes, including working capital, capital expenditures, acquisitions, funding of share repurchases and other payments, and repayment of all amounts outstanding under the Company’s previous revolving credit facility and term loans​.”

This suggests that more acquisitions may be in store in 2012, which would certainly fit with LabCorp’s stated aim of the diversification of its contract testing business in order to reduce its reliance on a few key customers in the pharmaceutical and biopharmaceutical sector.

With the completion of the Orchid deal LabCorp ends the year with two new divisions, the UK firm and Clearstone Central Labs which it bought in June​.

Related news

Show more

Related products

show more

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

Related suppliers

Follow us


View more